{"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"groups":[{"description":"Ponatinib 30 mg, tablets, orally, once daily (QD), with vincristine 1.4 mg/m\\^2 (max 2 mg) intravenous (IV), on Days 1 and 14 and dexamethasone 40 mg (\\<60 years \\[yrs\\]) and 20 mg (≥60 yrs), orally, once on Days 1 to 4, Days 11 to 14 for up to 3 cycles (each cycle=28 days) in induction phase (IP) (reduced dose of ponatinib 15 mg upon achievement of MRD-negative CR at end of induction) followed by ponatinib last induction phase dose with cytarabine, 1000 mg/m\\^2 as 2-hour IV infusion (\\<60 yrs) and 250 mg/m\\^2 (≥60 yrs) every 12 hours, IV on Days 1, 3, 5 of Cycles 2,4,6 and methotrexate, 1000 mg/m\\^2 (\\<60 yrs) and 250 mg/m\\^2 (≥60 yrs), IV infusion, on Day 1 of cycles 1, 3, 5 in consolidation phase (CP) followed by ponatinib last consolidation phase dose with vincristine 1.4 mg/m\\^2 (max 2 mg), IV, on Day 1 and prednisone 200 mg (\\<60 yrs), 100 mg (≥60-69 yrs) and 50 mg(≥70 yrs) on Days 1 to 5 for up to 11 cycles in maintenance phase (MP) up to data cut-off date: 12 August 2022.","id":"BG000","title":"Cohort A: Ponatinib 30 mg"},{"description":"Imatinib 600 mg, tablets, orally, QD, with vincristine 1.4 mg/m\\^2 (max 2 mg), IV, on Days 1 and 14 and dexamethasone 40 mg (\\<60 yrs) and 20 mg (≥60 yrs), orally, once on Days 1 to 4 and Days 11 to 14 in each 28-day cycle for up to 3 cycles in the induction phase followed by imatinib 600 mg, tablets, orally, QD, with cytarabine, 1000 mg/m\\^2 every 12 hours as a 2-hour-IV infusion (\\<60 yrs) and 250 mg/m\\^2 every 12 hours (≥60 yrs), IV on Days 1, 3, and 5 of each 28-day even cycles (Cycles 2, 4, and 6), and methotrexate, 1000 mg/m\\^2 (\\<60 yrs) and 250 mg/m\\^2 (≥60 yrs), IV infusion, on Day 1 of each 28-day odd cycles (Cycle 1, 3, and 5) in consolidation phase followed by imatinib 600 mg, tablets, orally, QD, along with vincristine 1.4 mg/m\\^2 (max 2 mg), IV, on Day 1 and prednisone 200 mg (\\<60 yrs), 100 mg (≥60-69 yrs) and 50 mg (≥70 yrs) on Days 1 through 5 in each 28-day cycle up to 11 cycles in maintenance phase up to data cut-off date: 12 August 2022.","id":"BG001","title":"Cohort B: Imatinib 600 mg"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"16.09","value":"51.2"},{"groupId":"BG001","spread":"14.60","value":"50.6"},{"groupId":"BG002","spread":"15.59","value":"51.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"90"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"133"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"38"},{"groupId":"BG002","value":"112"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"31"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"13"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"104"},{"groupId":"BG001","value":"62"},{"groupId":"BG002","value":"166"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"30"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"59"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"105"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"161"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Non-Hispanic and Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"19"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Not reported"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Unknown"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Australia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"22"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"China"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Korea, South"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Taiwan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Austria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"10"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Greece"},{"categories":[{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"38"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"11"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Russia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"25"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Turkey"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"13"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Mexico"},{"categories":[{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"60"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Argentina"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"28"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"164"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"245"}],"units":"Participants"}],"title":"Brazil"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.980","value":"167.24"},{"groupId":"BG001","spread":"9.029","value":"167.27"},{"groupId":"BG002","spread":"9.662","value":"167.25"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"158"},{"groupId":"BG001","value":"76"},{"groupId":"BG002","value":"234"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number analyzed are the number of participants available for height at baseline.","title":"Height","unitOfMeasure":"centimeters (cm)"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"18.675","value":"74.17"},{"groupId":"BG001","spread":"18.565","value":"76.23"},{"groupId":"BG002","spread":"18.626","value":"74.86"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"163"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"244"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number analyzed are the number of participants available for weight at baseline.","title":"Weight","unitOfMeasure":"kilograms (kg)"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.261","value":"1.84"},{"groupId":"BG001","spread":"0.255","value":"1.86"},{"groupId":"BG002","spread":"0.258","value":"1.85"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"157"},{"groupId":"BG001","value":"76"},{"groupId":"BG002","value":"233"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number analyzed are the number of participants available for BSA at baseline.","title":"Body Surface Area (BSA)","unitOfMeasure":"meters squared (m^2)"}],"populationDescription":"ITT analysis set was defined as all participants who were randomized."}